KORU Medical forecasts FY2026 revenue of $47.5 million-$48.5 million
KRMD•FY2026 outlook
KORU Medical guided FY 2026 revenue to $47.5 million-$48.5 million, implying 15%-18% year-on-year growth.
Gross margin is forecast at 62%-64%.
The outlook calls for positive adjusted EBITDA and a cash balance above $7.5 million by year-end.
Prior-year and cash balance figures
FY 2025 revenue was $41.1 million.
Q2 cash balance was $8.3 million.
